Skip to content
Screener

Arrowhead Research ARWR Contract Liabilities

Contract Liabilities at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$63.03M-49.6%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$11.78M
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$8.1M
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$0

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemMarch 31, 2026September 30, 2025
Total current liabilities295,220195,487
Long-term liabilities:
Lease liabilities, net of current portion100,106104,112
Deferred revenue, net of current portion48,615
Liability related to the sale of future royalties383,829367,397
Credit facility, net of current portion159,639214,883
Convertible notes, net681,940
Total long-term liabilities1,374,129686,392

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's contract liabilities?
Arrowhead Research (ARWR) reported contract liabilities of $48.62M in Q1 2026.
What is the long-term trend for Arrowhead Research's contract liabilities?
Over 3 years (2021 to 2025), Arrowhead Research's contract liabilities has grown at a -100.0% compound annual growth rate (CAGR), from $131.5M to $0.
What does contract liabilities mean?
Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.

Ask your AI about Arrowhead Research's contract liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude